- Unmet Needs in the Treatment of Gastroesophageal Reflux Disease
-
Dickman R, Maradey-Romero C, Gingold-Belfer R, Fass R
- KMID: 2433470
- J Neurogastroenterol Motil.
- 2015 Jul;21(3):309-319.
- doi: 10.5056/jnm15105
Gastroesophageal reflux disease (GERD) is a highly prevalent gastrointestinal disorder. Proton pump inhibitors have profoundly revolutionized the treatment of GERD. However, several areas of unmet need persist despite marked improvements... -
- CITED
-
- Close
- SHARE
-
- Close
- New and Future Drug Development for Gastroesophageal Reflux Disease
-
Maradey-Romero C, Fass R
- KMID: 2381145
- J Neurogastroenterol Motil.
- 2014 Jan;20(1):6-16.
Medical therapy remains the most popular treatment for gastroesophageal reflux disease (GERD). Whilst interest in drug development for GERD has declined over the last few years primarily due to the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes with of the Contix Faecal Incontinence Management System: preliminary results
-
Venturero M, Yehuda-Margalit R, Maradey-Romero C, Corcos Y, Carter D, Beer-Gabel M
- KMID: 2539720
- Ann Coloproctol.
- 2023 Feb;39(1):89-93.
- doi: 10.3393/ac.2022.00563.0080
Fecal incontinence (FI) has a significant long-term impact on patient quality of life for which there is a range of medical and surgical management alternatives. We report the preliminary outcome... -
- CITED
-
- Close
- SHARE
-
- Close
